Breaking News Instant updates and real-time market news.

BIOS

BioScrip

$2.54

0.095 (3.89%)

09:10
05/17/18
05/17
09:10
05/17/18
09:10

BioScrip announces resignation of Chief Accounting Officer

BioScrip disclosed last night that on May 14, Anthony Lopez stepped down as Chief Accounting Officer. Alex Schott, BioScrip's interim Chief Accounting Officer, will remain in that position until a new Chief Accounting Officer is appointed.

  • 29

    May

BIOS BioScrip
$2.54

0.095 (3.89%)

12/19/17
JEFF
12/19/17
NO CHANGE
JEFF
Jefferies sees attractive leveraged buyout candidates in Healthcare Services
The changing healthcare landscape, as well as the cyclicality of sector trends and the expected demographics-driven inflection in broader healthcare utilization in the coming years, have opened opportunities for increased private equity involvement in the Healthcare Services group, Jefferies analyst Brian Tanquilut tells investors in a research note. The analyst's quantitative screen and qualitative analysis points to Acadia (ACHC), BioScrip (BIOS) and Envision Healthcare (EVHC) as the "most feasible" leverage buyout candidates in his coverage universe. Tanquilut notes that while AmerisourceBergen (ABC) and McKesson (MCK) also screened as potential leveraged buyout candidates in his analysis, the equity checks required to take both private are likely too large, even for a consortium.
01/29/18
LSCM
01/29/18
NO CHANGE
Target $4.5
LSCM
Buy
BioScrip named a best idea for 2018 at Lake Street
Lake Street analyst Brooks O'Neil names BioScrip a best idea for 2018 following the stock's 180% rise in 2017. The analyst expects management to "continue to strengthen operations and deliver solid results in 2018." The analyst thinks that despite stalling in the Senate, the Cures Fix legislation will emerge for 2019. He keeps a Buy rating on BioScrip with a $4.50 price target.
03/08/18
CHLM
03/08/18
NO CHANGE
Target $3.5
CHLM
Buy
BioScrip price target raised to $3.50 from $2.50 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich raised his price target for BioScrip to $3.50 and maintains a Buy rating on the shares. The stock is down due to an internal accounting review that could delay the annual report filing, but the company's Q4 results were better than expected, highlighted by significant gross margin expansion and solid free cash flow, Ellich tells investors in a post-earnings research note. The analyst thinks the company's adjusted EBITDA guidance could prove to be conservative. He admits, though, that it may "take time for the dust to settle" regarding the internal accounting review.
03/09/18
BRRR
03/09/18
NO CHANGE
Target $3.5
BRRR
Outperform
BioScrip shares should be bought now, says Barrington
Barrington analyst Michael Petusky says BioScrip shares should be bought now following the 15.5% selloff on the company's Q4 results. BioScrip reported "strong" Q4 results, and the investment decisions weighing on the 2018 outlook make sense, Petusky tells investors in a research note. He maintains an Outperform rating on the shares with a $3.50 price target.

TODAY'S FREE FLY STORIES

WBC

Wabco

$114.86

-0.6 (-0.52%)

05:37
09/19/18
09/19
05:37
09/19/18
05:37
Hot Stocks
Wabco signs strategic agreement with RIO »

WABCO Holdings has signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 06

    Nov

BABA

Alibaba

$156.64

-2.12 (-1.34%)

05:36
09/19/18
09/19
05:36
09/19/18
05:36
Hot Stocks
Alibaba Cloud to work with Kenyan Ministry to protect wildlife »

Alibaba Cloud, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

WBC

Wabco

$114.86

-0.6 (-0.52%)

05:33
09/19/18
09/19
05:33
09/19/18
05:33
Hot Stocks
Wabco, Valeo sign MoU to develop sensor technologies »

Wabco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 18

    Oct

  • 06

    Nov

GE

General Electric

$12.67

-0.04 (-0.31%)

05:25
09/19/18
09/19
05:25
09/19/18
05:25
Hot Stocks
GE Transportation locomotives approved for operation by Indian Railways »

GE Transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

DCPH

Deciphera

$36.16

1.48 (4.27%)

, NVS

Novartis

$85.03

-0.1 (-0.12%)

05:21
09/19/18
09/19
05:21
09/19/18
05:21
Recommendations
Deciphera, Novartis, Blueprint Medicines analyst commentary  »

Piper recommends…

DCPH

Deciphera

$36.16

1.48 (4.27%)

NVS

Novartis

$85.03

-0.1 (-0.12%)

BPMC

Blueprint Medicines

$70.95

2.33 (3.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

  • 27

    Nov

CLCT

Collectors Universe

$15.04

-0.26 (-1.70%)

05:14
09/19/18
09/19
05:14
09/19/18
05:14
Hot Stocks
Collectors Universe announces termination of COO David Hall »

Collectors Universe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MB

Mindbody

$41.05

1 (2.50%)

05:12
09/19/18
09/19
05:12
09/19/18
05:12
Recommendations
Mindbody analyst commentary  »

Mindbody comments on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$92.60

-2.77 (-2.90%)

05:07
09/19/18
09/19
05:07
09/19/18
05:07
Recommendations
AbbVie analyst commentary  »

Piper more worried about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$102.16

-1.3 (-1.26%)

05:01
09/19/18
09/19
05:01
09/19/18
05:01
Downgrade
LyondellBasell rating change  »

LyondellBasell downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSEZY

SSE

$0.00

(0.00%)

04:57
09/19/18
09/19
04:57
09/19/18
04:57
Upgrade
SSE rating change  »

SSE upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HHC

Howard Hughes

$124.65

-0.88 (-0.70%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Howard Hughes management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

BAESY

BAE Systems

$0.00

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
BAE Systems management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Housing Starts to be reported at 08:30 »

August Housing Starts…

NEE

NextEra Energy

$173.44

-0.41 (-0.24%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
NextEra Energy management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 11

    Nov

RWT

Redwood Trust

$16.42

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Redwood Trust management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

AMSF

Amerisafe

$63.80

-0.35 (-0.55%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Amerisafe management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

NHI

National Health Investors

$76.47

-1.07 (-1.38%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
National Health Investors management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

AKTS

Akoustis

$8.08

0.04 (0.50%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Akoustis management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

NICE

Nice Systems

$115.64

-0.61 (-0.52%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Nice Systems management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GCI

Gannett

$9.92

0.135 (1.38%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Gannett management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

ATTO

Atento

$7.60

-0.1 (-1.30%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Atento management to meet with Barrington »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
RBC Capital hardware analyst to hold a group luncheon »

Hardware & Semis…

ALLK

Allakos

$44.88

0.95 (2.16%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

WCN

Waste Connections

$80.19

0.745 (0.94%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Waste Connections participates in a conference call with UBS »

Analyst Windham holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Breaking General news story  »

Week of 9/14 EIA…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.